发明名称 | Inhibitor of analgesic tolerance | ||
摘要 | Provided are: an agent for suppressing an undesirable effect of an opioid-type analgesic (opioid), which comprises a compound having adenosine A2A receptor antagonistic activity or a pharmaceutically acceptable salt thereof as an active ingredient; the agent for suppressing an undesirable effect of an opioid-type analgesic (opioid), wherein the undesirable effect of the opioid-type analgesic (opioid) is analgesic tolerance or constipation; the agent for suppressing an undesirable effect of an opioid-type analgesic (opioid), wherein the undesirable effect of the opioid-type analgesic (opioid) is analgesic tolerance; and the like. | ||
申请公布号 | US8865731(B2) | 申请公布日期 | 2014.10.21 |
申请号 | US200912994923 | 申请日期 | 2009.05.29 |
申请人 | Kyowa Hakko Kirin Co., Ltd. | 发明人 | Ouchi Jun;Kunori Shunji;Kojima Yozo;Shinoda Katsumi;Sasaki Katsutoshi;Shirakura Shiro |
分类号 | A01N43/90;A61K31/522;A61K31/52;A01N43/64;A61K31/41;A01N43/78;A61K31/425;A01N43/54;A61K31/517;A61K31/519;C07D471/04;C07D471/22;C07D487/04;C07D473/00;C07D273/00;C07D239/02;C07D249/16;C07D403/00;A61K31/4439;C07D473/34;C07D473/06;C07D487/14;C07D417/04;C07D417/14;A61K31/506;A61K45/06;A61K31/343;A61K31/427;A61K31/485 | 主分类号 | A01N43/90 |
代理机构 | Fitzpatrick, Cella, Harper & Scinto | 代理人 | Fitzpatrick, Cella, Harper & Scinto |
主权项 | 1. A method for suppressing an undesirable effect of an opioid, which comprises administering an effective amount of a compound represented by at least one of formulae (I) to (VIII), or a pharmaceutically acceptable salt thereof: in which R1 represents a hydrogen atom or methyl; R2 and R3 independently represent methyl, ethyl, propyl, butyl or isopropyl; R4, R5 and R6 independently represent a hydrogen atom, methyl, ethyl, methoxy, ethoxy, a fluorine atom, a chlorine atom or a bromine atom; R7 represents methyl, ethyl, propyl, butyl or 3-methylbutyl, each of which is optionally substituted with hydroxy; R8 represents phenyl, pyridyl, pyrimidinyl or 5,6-dihydro-2H-pyridylmethyl, each of which is optionally substituted with 1 to 3 substituents selected from the group consisting of a chlorine atom, methyl, ethyl, methoxy and ethoxy; R9 represents pyridyl or tetrahydropyranyl; R10 and R11 independently represent a hydrogen atom, a fluorine atom or 2-methoxyethoxy; and R12 represents methyl, ethyl, propyl or butyl, wherein said undesirable effect is analgesic tolerance. | ||
地址 | Tokyo JP |